Comparison between the Flapless Surgical Approach and a Novel Single Incision Access in Terms of Recovery Time and Comfort after Extraction of Impacted Inferior Third Molars: A Randomised, Blinded, Split-Mouth Controlled Clinical Trial.
flap design
impacted tooth
mandibular molar
maxillofacial surgery
oral surgery
third molar extraction
third molar surgery
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
02 Mar 2023
02 Mar 2023
Historique:
received:
31
01
2023
revised:
28
02
2023
accepted:
01
03
2023
entrez:
11
3
2023
pubmed:
12
3
2023
medline:
12
3
2023
Statut:
epublish
Résumé
The recent attention to quality of life and oral health care procedures reflects a renewed 'patient-based' approach to dealing with non-life-threatening conditions. In the current study, we proposed a novel surgical approach to the extraction of impacted inferior third molars (iMs3) through a randomised, blinded, split-mouth controlled clinical trial following the CONSORT guidelines. The novel surgical procedure, hereinafter referred to as single incision access (SIA), will be compared with our previously described flapless surgical approach (FSA). The predictor variable was the novel SIA approach, involving access through a single incision without removal of soft tissue, on the impacted iMs3. The primary endpoint was the acceleration of the iMs3 extraction healing time. The secondary endpoints were the incidences of pain and oedema as well as gum health (pocket probing depth and attached gingiva). The study was carried out on 84 teeth of 42 patients with both iMs3 impacted. The cohort was composed of 42% Caucasian males and 58% Caucasian females, aged 23.8 ± 7.9 (17-49) years. We observed faster recovery/wound-healing on the SIA side (33.6 ± 4.3 days) than at the FSA side (42.1 ± 5.4 days;
Identifiants
pubmed: 36902781
pii: jcm12051995
doi: 10.3390/jcm12051995
pmc: PMC10004479
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Int J Oral Maxillofac Surg. 2006 Apr;35(4):343-7
pubmed: 16280233
PLoS One. 2019 Jul 31;14(7):e0219536
pubmed: 31365529
Arch Oral Biol. 2019 Nov;107:104486
pubmed: 31374491
J Oral Maxillofac Surg. 1990 Jun;48(6):617-20
pubmed: 2341942
J Oral Maxillofac Surg. 2007 Nov;65(11):2206-10
pubmed: 17954315
J Clin Med. 2021 Feb 04;10(4):
pubmed: 33557388
Med Oral Patol Oral Cir Bucal. 2020 Mar 1;25(2):e233-e239
pubmed: 32062667
J Biol Regul Homeost Agents. 2019 May-Jun;33(3 Suppl. 1):169-172. DENTAL SUPPLEMENT
pubmed: 31538464
J Oral Maxillofac Surg. 2004 Sep;62(9):1118-24
pubmed: 15346364
Ann Med Surg (Lond). 2022 Aug 21;81:104387
pubmed: 36147052
J Clin Exp Dent. 2019 Jan 01;11(1):e55-e61
pubmed: 30697395
J Oral Maxillofac Surg. 2006 Dec;64(12):1721-30
pubmed: 17113437
J Oral Maxillofac Surg. 2003 Jul;61(7):759-63; discussion 764-5
pubmed: 12856246
J Oral Maxillofac Surg. 2015 Jun;73(6):1031-41
pubmed: 25872465
J Oral Maxillofac Surg. 2019 Nov;77(11):2222.e1-2222.e9
pubmed: 31306615
J Oral Maxillofac Surg. 2012 Apr;70(4):779-86
pubmed: 22177812
J Stomatol Oral Maxillofac Surg. 2020 Feb;121(1):63-69
pubmed: 31476533
Int J Oral Maxillofac Surg. 2019 Nov;48(11):1456-1469
pubmed: 31078366
Br Dent J. 1991 Apr 6;170(7):257-62
pubmed: 1827339
Front Psychiatry. 2022 Aug 18;13:956566
pubmed: 36061304
Ann Maxillofac Surg. 2018 Jul-Dec;8(2):206-213
pubmed: 30693233
Qual Life Res. 2018 Oct;27(10):2477-2489
pubmed: 29797177
J Oral Biol Craniofac Res. 2022 Sep-Oct;12(5):694-701
pubmed: 36092459